Power Law company profile

Celcuity

Biotech & Life Sciences · Minneapolis, United States · Founded 2012 · IPO 2017 Unicorn

Precision oncology therapies guided by companion diagnostics

Valuation

$5.74B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

6 investors on Celcuity's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Brightstone Venture Capital

Series B+ 5 investors entered at this stage

Commodore Capital

Venrock Healthcare Capital Partners

NEA

RA Capital Management

Soleus Capital

Global footprint

Where Celcuity has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States98.4%

🇭🇺 Hungary1.3%

🇵🇱 Poland1.2%

3 countries shown

Web traffic by country

12K monthly visits
across markets

🇺🇸 United States85%

🇮🇳 India14.2%

🇫🇷 France0.8%

Top 3 markets shown

Patent intelligence

$9M patent portfolio · 8 active families

Estimated portfolio value

$9M

0.15% of market cap · 19.1× smaller than top peer Amicus Therapeutics ($164M)

8 active patent families

Where Celcuity innovates PharmacologyGEDATOLISIBOncologyPiperidineCell

Where Celcuity concentrates vs peers

Each axis is a top-10 topic across Celcuity and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Celcuity

An AI-synthesized read of the highest-engagement posts about Celcuity on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Celcuity on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles